Overview

Evaluate Safety, Efficacy and Pharmacokinetics

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate equivalent pharmacokinetics (PK)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Celltrion
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Trastuzumab